Anti-thymocyte globulin at a total dose of 2.5mg/kg for acute graft-versus-host disease prophylaxis after unrelated haematopoietic stem cell transplantation for acute myelogenous leukaemia

被引:0
|
作者
Min, W. S. [1 ]
Kim, H. J. [1 ]
Cho, B. S. [1 ]
Kim, Y. J. [1 ]
Min, C. K. [1 ]
Lee, S. [1 ]
Cho, S. G. [1 ]
Lee, J. W. [1 ]
Kim, C. C. [1 ]
机构
[1] Catholic Univ Korea, Seoul, South Korea
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S411 / S411
页数:1
相关论文
共 50 条
  • [1] Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation
    Al-Kadhimi, Zaid
    Gul, Zartash
    Rodriguez, Roberto
    Chen, Wei
    Smith, Daryn
    Mitchell, Alice
    Abidi, Muneer
    Ayash, Lois
    Deol, Abhinav
    Lum, Lawrence
    Forman, Stephen
    Ratanatharathorn, Voravit
    Uberti, Joseph
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (11) : 1734 - 1744
  • [2] LOW DOSE ANTI-THYMOCYTE GLOBULIN FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS OF MISMATCHED UNRELATED PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
    Kim, H. -J
    Min, W. -S
    Eom, K. -S
    Cho, B. -S
    Min, C. -K
    Lee, S.
    Cho, S. -G
    Lee, J. -W
    Kim, C. -C
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 138 - 138
  • [3] Outcomes of unrelated donor stem cell transplantation with or without anti-thymocyte globulin used as graft-versus-host disease prophylaxis in patients with acute leukaemia and myelodysplastic syndrome
    Gener, Georgina
    Batlle, Montserrat
    Morgades, Mireia
    Jimenez, Maria-Jose
    Ferra, Christelle
    Ribera, Josep-Maria
    [J]. MEDICINA CLINICA, 2021, 157 (08): : 380 - 384
  • [4] Low dose rabbit anti-thymocyte globulin for graft versus host disease prophylaxis after unrelated hematopoietic stem cell transplantation in pediatric patients
    Atay, Didem
    Erbey, Fatih
    Akcay, Arzu
    Akmuradova, Aygozel
    Seferkolli, Florenc
    Ozturk, Gulyuz
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 431 - 432
  • [5] Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
    Osamu Imataki
    Kensuke Matsumoto
    Makiko Uemura
    [J]. Journal of Cancer Research and Clinical Oncology, 2017, 143 : 709 - 715
  • [6] Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
    Imataki, Osamu
    Matsumoto, Kensuke
    Uemura, Makiko
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (04) : 709 - 715
  • [7] Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia
    Keogh, Steven J.
    Dalle, Jean-Hugues
    Admiraal, Rick
    Pulsipher, Michael A.
    [J]. FRONTIERS IN PEDIATRICS, 2022, 9
  • [8] Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin
    Remberger, M
    Aschan, J
    Barkholt, L
    Tollemar, J
    Ringdén, O
    [J]. CLINICAL TRANSPLANTATION, 2001, 15 (03) : 147 - 153
  • [9] Tacrolimus versus cyclosporine A in prophylaxis of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in patients with acute leukaemia
    Stankevich, Y.
    Zubarovskaya, L.
    Vavilov, V.
    Bondarenko, S.
    Darskaya, E.
    Kulagin, A.
    Afanasyev, B.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S153 - S154
  • [10] The beneficial impact of incorporation of low-dose anti-thymocyte globulin (rabbit) 5mg/kg to standard graft-versus-host disease prophylaxis in matched or mismatched unrelated allogeneic stem cell transplantation
    Batsis, I.
    Mallouri, D.
    Bousiou, Z.
    Constantinou, V.
    Apostolou, C.
    Tsirou, K.
    Kaloyannidis, P.
    Smias, C.
    Yannaki, E.
    Fylaktou, A.
    Anagnostopoulos, A.
    Sakellari, I.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S178 - S179